Natixis Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-13,251	Closed	-$1.93M	–	1541
2022 Q2	$1.93M	Buy	+13,251	New	+$1.93M	0.01%	922
2022 Q1	–	Sell	-11,586	Closed	-$1.6M	–	1494
2021 Q4	$1.6M	Buy	+11,586	New	+$1.6M	0.01%	1013